bezafibrate has been researched along with Autoimmune Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bowlus, CL; Liu, CH | 1 |
| de Veer, RC; Laschtowitz, A; Schramm, C; Van der Meer, AJ | 1 |
| Kurihara, T; Maeda, A; Niimi, A; Shigemoto, M; Yamashita, K | 1 |
2 review(s) available for bezafibrate and Autoimmune Diseases
| Article | Year |
|---|---|
Treatment of Primary Biliary Cholangitis: First-Line and Second-Line Therapies.
Topics: Autoimmune Diseases; Bezafibrate; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |
Diagnosis and treatment of primary biliary cholangitis.
Topics: Autoantigens; Autoimmune Diseases; Bezafibrate; Biomarkers; Biopsy; Chenodeoxycholic Acid; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Elasticity Imaging Techniques; End Stage Liver Disease; Fatigue; Female; Humans; Immunoglobulin M; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Middle Aged; Off-Label Use; Prognosis; Pruritus; Quality of Life; Severity of Illness Index; Sjogren's Syndrome; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
1 trial(s) available for bezafibrate and Autoimmune Diseases
| Article | Year |
|---|---|
Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid.
Topics: Aged; Autoimmune Diseases; Bezafibrate; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid | 2000 |